CN Patent

CN101715451A — 新型的吡啶并吡嗪衍生物，其制备方法和用途

Assigned to Aeterna Zentaris GmbH · Expires 2010-05-26 · 16y expired

What this patent protects

本发明涉及通式(Ia)和(Ib)所示的新型的吡啶并[2，3-b]吡嗪衍生物及其制备方法及其作为药物、特别是作为用于治疗恶性疾病和治疗其它的基于病理性细胞增殖的疾病的药物的用途。

USPTO Abstract

本发明涉及通式(Ia)和(Ib)所示的新型的吡啶并[2，3-b]吡嗪衍生物及其制备方法及其作为药物、特别是作为用于治疗恶性疾病和治疗其它的基于病理性细胞增殖的疾病的药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101715451A
Jurisdiction
CN
Classification
—
Expires
2010-05-26
Drug substance claim
No
Drug product claim
No
Assignee
Aeterna Zentaris GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.